Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Alcobra Ltd. (ADHD)

-NasdaqGM
17.42 Down 0.60(3.33%) Jul 31, 4:00PM EDT
|After Hours : 17.42 0.00 (0.00%) Jul 31, 4:01PM EDT
Prev Close:18.02
Open:17.87
Bid:16.50 x 100
Ask:25.30 x 1400
1y Target Est:N/A
Beta:1.935
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:17.30 - 18.00
52wk Range:11.49 - 26.96
Volume:98,852
Avg Vol (3m):108,709
Market Cap:237.54M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADHD

Comparison

Symbol% ChgMkt Cap
ADHDDown 3.33%237.54M
JNJDown 2.16%283.16B
NVSDown 1.70%210.93B
SHPGDown 1.89%48.18B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of proprietary drug candidates. It offers most advanced product (MDX) for the treatment of attention deficit hyperactivity disorder (ADHD) and other cognit... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback